*SEE LEGAL DISCLAIMER BELOW
7-31-17 | Several of the world’s leading diabetes companies have said the results we have achieved with our proprietary oral insulin formulation in animals are “unprecedented” – and we are just getting started. For a limited time only, we are extending this private invitation to qualified investors to help us carry our MxBA™ oral drug delivery technology to market. We are about to change the future of healthcare forever and we want you to join us in this rewarding opportunity. VC and Angel investor opportunities available.
To find out how you can apply to join Tamarisk’s private family of shareholders, please contact Mr. Dean Crowell at
firstname.lastname@example.org | 702.516.6451
Note: Whether establishing contact via email or phone, please include your Name, telephone number, preferred email address for contact, and initial questions or nature of interest.
ABOUT THE CURRENT INVESTMENT OPPORTUNITY
Download Slide Deck: Click Here
Tamarisk rNPV – Click Here
- Seeking $5 million capital/debt financing or other non-dilutive Funding
- Technology Patented novel platform oral drug delivery technology (MxBA™) for new and current drugs with poor oral absorption
- Current Status
- Have demonstrated efficacy in small rodent studies multiple times
- Significant interest from multiple pharmaceutical companies
- In discussions with a large pharmaceutical company to apply our technology for two diabetic drugs. Tamarisk recently signed an agreement to begin a Feasibility study in September 2017. (More info available upon signing CDA)
- Strategy License core technology to pharmaceutical drug innovators
- Seeking Investment partners to assist in accelerating our business strategy
- Funding to date: Self Funded to $6 million | seeking $5 million in debt financing
- Team Focus Lean core team focused on proof of concept studies and advancing licensee discussions
*Confidentiality By continuing to view this site, specifically this information regarding potential investment opportunities with Tamarisk, you agree to due your own due diligence and maintain strict confidentiality regarding this opportunity. The Site includes Materials that are confidential to Tamarisk Technologies Group and its licensors and suppliers. You should assume that the Materials are confidential and proprietary unless otherwise indicated on the Site or apparent from the nature of such Materials (for example, publicly available forms, presentations, or other documents). You agree to maintain such Materials in strict confidence, to only share Materials with other employees who have a need to know for the purpose of supporting Tamarisk’s or Tamarisk’s client’s business, to use such Materials only as provided hereunder, and not to disclose such Materials to third parties. You agree to store and handle the Materials in such a way as to prevent unauthorized disclosure, to take reasonable measures to protect the Materials and treat them with the same degree of care with which you treat your own and your employer’s proprietary information, and, in no event, use less than reasonable care. This obligation will not apply to Materials that Visa has made generally available to the public.
Tamarisk legal information Tamarisk Technologies Group, including its subsidiaries, licensees, and affiliates (“Tamarisk”), maintains or arranges for the maintenance of Tamarisk Online (the “Site”) as a service to interested parties. The information and materials provided through the Site, including any data, text, graphics, images, audio and video clips, logos, icons, software, form documents, and links (collectively, the “Materials”), are intended to educate and assist our clients and potential investors. Any person who uses or otherwise accesses the Site or the Materials, however, must abide by the following terms, as amended from time to time (the “Terms”), and must abide by all applicable laws and regulations. The Terms may be changed by Tamarisk in the future. It is your responsibility as a user of the Site and Materials to return periodically to this page to review the Terms for amendments. Tamarisk reserves the right, without notice and for any reason, to remove any Material from the Site, and to deny access by any user to all or any part of the Site and to terminate this agreement in part or in whole.
Indemnity: You agree to indemnify and hold Tamarisk Technologies Group, its officers, directors, shareholders, predecessors, successors in interest, employees, agents, subsidiaries and affiliates, harmless from any demands, loss, liability, claims or expenses (including attorneys’ fees), made against Tamarisk by any third party due to or arising out of or in connection with your use of the Site and the files contained herein.